Regulation of kindling epileptogenesis by hippocampal galanin type 1 and type 2 receptors: The effects of subtype-selective agonists and the role of G-protein-mediated signaling

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 2, 2006, Pages 700-708

  Mazarati, Andréy ^a   Lundström, Linda ^b   Sollenberg, Ulla ^b   Shin, Don ^a   Langel, Ülo ^b   Sankar, Raman ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DANTROLENE; GALANIN; GALANIN RECEPTOR 1; GALANIN RECEPTOR 2; GALANIN(1-13)GLUTAMYL BRADIKININ(2-9)AMIDE; GALANIN(2-11); GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN INHIBITOR; SPANTIDE; TERTIAPIN Q; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; EPILEPTOGENESIS; HIPPOCAMPUS; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTICONVULSANTS; BEE VENOMS; CALCIUM SIGNALING; DANTROLENE; ELECTRIC STIMULATION; EPILEPSY; FLUORESCENT DYES; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GALANIN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; GTP-BINDING PROTEINS; HIPPOCAMPUS; KINDLING, NEUROLOGIC; LIMBIC SYSTEM; MALE; MUSCLE RELAXANTS, CENTRAL; PERTUSSIS TOXIN; RATS; RATS, WISTAR; RECEPTOR, GALANIN, TYPE 1; RECEPTOR, GALANIN, TYPE 2; SIGNAL TRANSDUCTION;

EID: 33745963016     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.104703     Document Type: Article

References (40)

1. Badie-Mahdavi H, Lu X, Behrens MM, and Bartfai T (2005) Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3′,5′-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice. Neuroscience 133:591-604.
2. Bartfai T, Lu X, Badie-Mahdavi H, Barr AM, Mazarati A, Hua X, Yaksh T, Haberhauer G, Trembleau L, Conde Ceide S, et al. (2004) Galmic, a non peptide galanin receptor agonist, affects behaviors in seizure, pain and forced swim tests. Proc Natl Acad Sci USA 101:10470-10475.
3. Bokoch GM, Katada T, Northup JK, Hewlett EL, and Gilman AG (1983) Identification of the predominant substrate for ADP-ribosylation by islet activating protein. J Biol Chem 258:2072-2075.
4. Burchfiel JL, Duchowny MS, and Duffy FH (1979) Neuronal supersensitivity to acetylcholine induced by kindling in the rat hippocampus. Science (Wash DC) 204:1096-1098.
5. Counts SE, McGuire SO, Sortwell CE, Crawley JN, Collier TJ, and Mufson E (2002) Galanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons. J Neurochem 83:442-451.
6. Goh JW and Pennefather PS (1989) A pertussis toxin-sensitive G protein in hippocampal long-term potentiation. Science (Wash DC) 244:980-983.
7. Haberman RP, Samulski RJ, and McCown TJ (2003) Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat Med 9:1076-1080.
8. Jacoby AS, Hort YJ, Constantinescu G, Shine J, and Iismaa TP (2002) Critical role for GALR1 galanin receptor in galanin regulation of neuroendocrine function and seizure activity. Mol Brain Res 107:195-200.
9. + channels. Biochemistry 37:13291-13299.
10. Kashihara K, Sato K, Akiyama K, Ishihara T, Hayabara T, and Abe K (2000) Temporal profile of CRE DNA-binding activity in the rat hippocampus following a kindling stimulation. Epilepsy Res 40:171-177.
11. Kask K, Berthold M, Bourne J, Andell S, Langel U, and Bartfai T (1995) Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9) amide chimeric peptide, in Rin m 5F insulinoma cells. Regul Pept 59:341-348.
12. Kokaia M, Holmberg K, Nanobashvili A, Xu ZQ, Kokaia Z, Lendahl U, Hilke S, Theodorsson E, Kahli U, Bartfai T, et al. (2001) Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc Natl Acad Sci USA 98:14006-14011.
13. Lauckner JE, Hille B, and Mackie K (2005) The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc Natl Acad Sci USA 102:19144-19149.
14. + channels. Mol Cell 15:1-9.
15. Lin EJ, Richichi C, Young D, Baer K, Vezzani A, and During MJ (2003) Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur J Neurosci 18:2087-2092.
16. Liu H, Mazarati AM, Katsumori H, Sankar R, and Wasterlain CG (1999) Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. Proc Natl Acad Sci USA 96:5286-5291.
17. Liu HX, Brumovsky P, Schmidt R, Brown W, Payza K, Hodzic L, Pou C, Godbout C, and Hökfelt T (2001) Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors. Proc Natl Acad Sci USA 98:9960-9964.
18. Löscher W (2002) Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs: a comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50:105-123.
19. Lothman EW, Hatlelid JM, Zorumski CF, Conry JA, Moon PF, and Perlin JB (1985) Kindling with rapidly recurring hippocampal seizures. Brain Res 360:83-91.
20. Lu X, Lundstrom L, and Bartfai T (2005) Galanin(2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes. Neuropeptides 39:165-167.
21. Lundström L, Elmquist A, Bartfai T, and Langel U (2005a) Galanin and its receptors in neurological disorders. Neuromol Med 7:157-180.
22. Lundström L, Sollenberg U, Brewer A, Kouya PF, Zheng K, Xu X-J, Sheng X, Robinson JK, Wiesenfeld-Hallin Z, Xu Z-Q, et al. (2005b) A galanin receptor subtype 1 specific agonist. Int J Peptide Res Ther 11:17-27.
23. Mazarati AM, Baldwin RA, Shinmei S, and Sankar R (2005) In vivo interaction between serotonin and galanin type 1 and type 2 receptors in dorsal raphe: implication for limbic seizures. J Neurochem 95:1495-1503.
24. Mazarati AM, Hohmann JG, Bacon A, Liu H, Sankar R, Steiner RA, Wynick D, and Wasterlain CG (2000) Modulation of hippocampal excitability and seizures by galanin. J Neurosci 20:6276-6281.
25. Mazarati AM, Liu H, Soomets U, Sankar R, Shin D, Katsumori H, Langel U, and Wasterlain CG (1998) Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J Neurosci 18:10070-10077.
26. Mazarati AM and Lu X (2005) Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors. Neuropeptides 39:277-280.
27. Mazarati AM, Lu X, Kilk K, Langel U, Wasterlain CG, and Bartfai T (2004a) Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. Eur J Neurosci 19:3235-3244.
28. Mazarati A, Lu X, Shinmei S, Badie-Mahdavi H, and Bartfai T (2004b) Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (galr1) knockout mice. Neuroscience 128:431-441.
29. Mennicken F, Hoffert C, Pelletier M, Ahmad S, and O'Donnell D (2004) Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system. J Chem Neuroanat 24:257-268.
30. Mitchell FM, Heasley LE, Qian NX, Zamarripa J, and Johnson GL (1995) Differential modulation of bombesin-stimulated phospholipase C β and mitogen-activated protein kinase activity by [D-Arg1,D-Phe5,D-Trp7,9,Leu11] substance P. J Biol Chem 270:8623-8688.
31. Moldrich RX, Chapman AG, De Sarro G, and Meldrum BS (2003) Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol 476:3-16.
32. Morimoto K, Fahnestock M, and Racine RJ (2004) Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73:1-60.
33. O'Donnell D, Ahmad S, Wahlestedt C, and Walker P (1999) Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J Comp Neurol 409:469-481.
34. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, CA.
35. 12 in Swiss 3T3cells. Biol Chem 275: 30644-30652.
36. Stables JP, Bertram E, Dudek FE, Holmes G, Mathern G, Pitkanen A, and White HS (2003) Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop. Epilepsia 44:1472-1478.
37. Suzuki K, Iwasa H, Kikuchi S, Sato T, Miyake M, Morinaga N, and Noda M (1997) The contribution of endogenous mono-ADP-ribosylation to kindling-induced epileptogenesis. Brain Res 745:109-113.
38. Wang S, Hashemi T, Fried S, Clemmons AL, and Hawes BE (1998) Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry 37:6711-6717.
39. Watanabe Y, Mori N, and Uemura S (1991) Suppression of kindled seizures following intraamygdaloid injection of pertussis toxin in rats. Neurosci Lett 130:199-202.
40. Wickenden AD (2002) Potassium channels as anti-epileptic drug targets. Neuropharmacology 43:1055-1060.